ES2019560A6 - Procedimiento de preparar polvos esteriles inyectables de antibioticos y aparato correspondiente. - Google Patents

Procedimiento de preparar polvos esteriles inyectables de antibioticos y aparato correspondiente.

Info

Publication number
ES2019560A6
ES2019560A6 ES9001152A ES9001152A ES2019560A6 ES 2019560 A6 ES2019560 A6 ES 2019560A6 ES 9001152 A ES9001152 A ES 9001152A ES 9001152 A ES9001152 A ES 9001152A ES 2019560 A6 ES2019560 A6 ES 2019560A6
Authority
ES
Spain
Prior art keywords
antibiotics
preparation
sterile powders
penicillins
cephalosporins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9001152A
Other languages
English (en)
Spanish (es)
Inventor
Flavio Dusci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PARENTA Srl
Original Assignee
PARENTA Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PARENTA Srl filed Critical PARENTA Srl
Publication of ES2019560A6 publication Critical patent/ES2019560A6/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D1/00—Evaporating
    • B01D1/16—Evaporating by spraying
    • B01D1/18—Evaporating by spraying to obtain dry solids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES9001152A 1989-04-27 1990-04-24 Procedimiento de preparar polvos esteriles inyectables de antibioticos y aparato correspondiente. Expired - Fee Related ES2019560A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8920292A IT1230095B (it) 1989-04-27 1989-04-27 Procedimento per la preparazione di forme sterili di polveri iniettabili di antibiotici.

Publications (1)

Publication Number Publication Date
ES2019560A6 true ES2019560A6 (es) 1991-06-16

Family

ID=11165487

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9001152A Expired - Fee Related ES2019560A6 (es) 1989-04-27 1990-04-24 Procedimiento de preparar polvos esteriles inyectables de antibioticos y aparato correspondiente.

Country Status (6)

Country Link
JP (1) JPH02295926A (it)
CA (1) CA2012727A1 (it)
DE (1) DE4011956A1 (it)
ES (1) ES2019560A6 (it)
GB (1) GB2231266A (it)
IT (1) IT1230095B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL372247A1 (en) 2002-02-01 2005-07-11 Pfizer Products Inc. Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
GB2404880B (en) 2003-07-25 2005-10-12 Ultrasound Brewery Ultrasonic solution separator
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
CN101299995B (zh) * 2005-12-05 2013-04-24 桑多斯股份公司 重构后稳定性提高的冻干哌拉西林钠的制备方法
WO2009081751A1 (ja) * 2007-12-21 2009-07-02 Nipro Corporation 抗生物質製剤の新規製造法
CN102372728B (zh) * 2011-11-28 2013-12-11 齐鲁安替制药有限公司 一种头孢菌素类化合物的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
GB1479655A (en) * 1974-03-08 1977-07-13 Beecham Group Ltd Antibiotic preparations
GB1532993A (en) * 1975-03-07 1978-11-22 Beecham Group Ltd Injectable antibiotic compositions
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile

Also Published As

Publication number Publication date
CA2012727A1 (en) 1990-10-27
JPH02295926A (ja) 1990-12-06
IT8920292A0 (it) 1989-04-27
IT1230095B (it) 1991-10-05
GB9008756D0 (en) 1990-06-13
GB2231266A (en) 1990-11-14
DE4011956A1 (de) 1990-10-31

Similar Documents

Publication Publication Date Title
AU4958590A (en) Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof
MY114211A (en) Powder formulations containing melezitose as a diluent
IL85972A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL95846A0 (en) Derivatives of 2-hydroxy-thiophene and-furan fused with a nitrogen-containing ring,their preparation and pharmaceutical compositions containing them
EA004302B9 (ru) β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ
GEP19971030B (en) Method for preparation of derivatives of 1-benzil-3-oximetil-indazolului or salts with pharmaceutically acceptable bases
EP0282057A3 (en) Chemo-radio-immuno-conjugates
YU54189A (en) Process for obtaining cephem derivatives and midproducts for the same
HUT37170A (en) Process for preparing bbm-2478 antibiotic complex and components thereof,namely bbm-2478a and bbm-2478b antibiotics, further pharmaceutical compositions containing thereof
ES2019560A6 (es) Procedimiento de preparar polvos esteriles inyectables de antibioticos y aparato correspondiente.
IL92791A0 (en) Annelated indolo(3,2-c)lactams,their preparation and pharmaceutical compositions containing them
IL87374A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
MY104937A (en) Cephalosporin derivatives and processes for their preparation
AU613228B2 (en) A new antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical
IE822371L (en) Pyrazinium substituted cephalosporins
IL89734A0 (en) Polypeptide derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL91001A0 (en) N-alkyl derivatives of antibiotic bu-3608 complex and pharmaceutical compositions containing them
AU4246489A (en) New benzoxazolinone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL85970A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
AU7878681A (en) Cephalosporin antibiotics and their oxygen, nitrogen and carbon analogues
MY114213A (en) Clavulanic acid salts
AU2051388A (en) Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same
IL100407A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL76967A (en) 3-(ar)alk-1-en-3-ynyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
ZA868518B (en) Cephalosporin derivatives and a process for their preparation

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971201